Translational study reveals a two-faced role of RBM3 in pancreatic cancer and suggests its potential value as a biomarker for improved patient stratification.
about
Translational study reveals a two-faced role of RBM3 in pancreatic cancer and suggests its potential value as a biomarker for improved patient stratification.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Translational study reveals a ...... proved patient stratification.
@en
Translational study reveals a ...... proved patient stratification.
@nl
type
label
Translational study reveals a ...... proved patient stratification.
@en
Translational study reveals a ...... proved patient stratification.
@nl
prefLabel
Translational study reveals a ...... proved patient stratification.
@en
Translational study reveals a ...... proved patient stratification.
@nl
P2093
P2860
P50
P356
P1433
P1476
Translational study reveals a ...... proved patient stratification.
@en
P2093
Adil Mardinoglu
Emelie Karnevi
Jacob Elebro
Jakob Eberhard
Liv Ben Dror
Margareta Heby
Sven-Erik Olofsson
William Gallagher
P2860
P304
P356
10.18632/ONCOTARGET.23486
P407
P577
2017-12-15T00:00:00Z